SBA Academy: Challenges in Drug Discovery and Development

Module 3: Manufacturing Processes -CHF 150.00 for members of SBA, swiTT, CTI-start-up companies and academia.
This course will give an insight into the requirements and issues in the manufacture of drug material in sufficient quality and quantitiy for the preclinical and clinical phases and how to manage the collaboration with CROs and suppliers.

 
Start Date 26.04.2013 - 09:00
Event End 26.04.2013 - 17:00
Location Universität Basel

 

This course will give an insight into the requirements and issues in the manufacture of drug material in sufficient quality and quantitiy for the preclinical and clinical phases and how to manage the collaboration with CROs and suppliers:

  • Pharma R&D: Issues and Perspectives (Hans Kocher, Novartis)
  • Dosage Form Design:
    From classical to "Right, First Time" workflow (Hans Leuenberger, University of Basel & CINAP)
    Case Presentation (Paul Ruffieux, SKAN)
  • Drug Substance Development
    Small Molecules vs. Biologics - Similarities and Differences (Robert Hett, Rapid Pharma Development)
    Case Presentation (Karlheinz Landauer, Celonic, Thomas Schlatterer, Carbogen Amcis)
  • Other CMC Issues
    Solid State Critera - the SSS Rule (Rolf Hilfiker, Solvias)
    Quality by Design and other Regulatory Aspects (Jutta Riedl, Swissmedic)
  • Keynote: Efficient management of Outsourcing (Manfred Schulz, Lumavita)

For more information click here